CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
research
Guidelines for the management of postmenopausal osteoporosis for GPs
Authors
Terry Diamond
Peter Ebeling
+12 more
Linda Ferris
Maria Fiatarone-Singh
David Findlay
Leon Flicker
Stephen Lord
Alistair MacLennan
Alex Markwell
Caryl Nowson
Sheila O\u27Neill
Nick Pocock
Philip Sambrook
Margaret Williamson
Publication date
1 January 2004
Publisher
'The Royal Australian College of General Practitioners'
Abstract
Copyright © 2004 Royal Australian College of General Practitioners Copyright to Australian Family Physician. Reproduced with permission. Permission to reproduce must be sought from the publisher, The Royal Australian College of General Practitioners.Background: Since the last series of guidelines on the management of osteoporosis from Osteoporosis Australia was published in Australian Family Physician (October 2002), there have been further advances in our understanding of the treatment involved in both the prevention of bone loss and the management of established osteoporosis. Objective: This article provides updated guidelines for the management of postmenopausal osteoporosis to assist general practitioners identify those women at risk, and reviews current treatment strategies. DISCUSSION: Osteoporosis and its associated problems are major health concerns in Australia, especially with an aging population. While important principles of management are still considered to be maximising peak bone mass and preventing postmenopausal bone loss, new clinical trial data about drugs such as the bisphosphonates, raloxifene and oestrogen have recently become available and the relative role of various agents is gradually becoming clearer. The use of long term hormone therapy has mixed risks and benefits that requires individual patient counselling.O'Neill S; MacLennan A; Bass S; Diamond T; Ebeling P; Findlay D; Flicker L; Markwell A; Nowson C; Pocock N; Sambrook P; Singh M
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Deakin Research Online
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dro.deakin.edu.au:DU:30008...
Last time updated on 22/08/2013
Adelaide Research & Scholarship
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:digital.library.adelaide.e...
Last time updated on 05/08/2013